User profiles for "author:Gabriele Simonini"
 | Gabriele SimoniniRheumatology Unit, ERN-ReCONNET center Meyer Children's Hospital IRCCS, University … Verified email at unifi.it Cited by 7183 |
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach
Objective. To summarize evidence regarding the effectiveness of MTX in the treatment of
childhood autoimmune chronic uveitis (ACU). Methods. A systematic search of articles …
childhood autoimmune chronic uveitis (ACU). Methods. A systematic search of articles …
Anakinra treatment in drug-resistant Behcet's disease: a case series
L Cantarini, A Vitale, P Scalini, CA Dinarello… - Clinical …, 2015 - Springer
The study objective was to report treatment with an interleukin (IL)-1 receptor antagonist,
anakinra, in patients with multiorgan Behcet's disease (BD). Comparison of clinical …
anakinra, in patients with multiorgan Behcet's disease (BD). Comparison of clinical …
Current Evidence of Anti–Tumor Necrosis Factor α Treatment Efficacy in Childhood Chronic Uveitis: A Systematic Review and Meta‐Analysis Approach of Individual …
Objective To summarize evidence regarding the effectiveness of anti–tumor necrosis factor α
(anti‐TNFα) treatments in childhood autoimmune chronic uveitis (ACU), refractory to …
(anti‐TNFα) treatments in childhood autoimmune chronic uveitis (ACU), refractory to …
Evidence of the transient nature of the Th17 phenotype of CD4+ CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis
Objective To investigate the phenotype and function of CD4+ T cells in synovial fluid (SF)
from the affected joints of children with oligoarticular‐onset juvenile idiopathic arthritis (JIA) …
from the affected joints of children with oligoarticular‐onset juvenile idiopathic arthritis (JIA) …
Prevention of flare recurrences in childhood‐refractory chronic uveitis: an open‐label comparative study of adalimumab versus infliximab
G Simonini, A Taddio, M Cattalini… - Arthritis care & …, 2011 - Wiley Online Library
Objective To compare the efficacy and safety of adalimumab versus infliximab in an open‐
label prospective, comparative, multicenter cohort study of childhood noninfectious chronic …
label prospective, comparative, multicenter cohort study of childhood noninfectious chronic …
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative
T Constantin, I Foeldvari, J Anton, J De Boer… - Annals of the …, 2018 - ard.bmj.com
Background In 2012, a European initiative called S ingle Hub and Access point for pediatric
Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic …
Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic …
Differentiating PFAPA syndrome from monogenic periodic fevers
OBJECTIVES: To analyze whether there were clinical differences between genetically
positive and negative patients fulfilling periodic fever, aphthous stomatitis, pharyngitis, and …
positive and negative patients fulfilling periodic fever, aphthous stomatitis, pharyngitis, and …
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry
ME Zannin, C Birolo, VM Gerloni, E Miserocchi… - The Journal of …, 2013 - jrheum.org
Objective. To evaluate safety and efficacy of adalimumab (ADA) and infliximab (IFX) for the
treatment of juvenile idiopathic arthritis-related anterior uveitis (JIA-AU). Methods. Starting …
treatment of juvenile idiopathic arthritis-related anterior uveitis (JIA-AU). Methods. Starting …
[HTML][HTML] Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic …
M Cattalini, S Della Paolera, F Zunica… - Pediatric …, 2021 - Springer
Background There is mounting evidence on the existence of a Pediatric Inflammatory
Multisystem Syndrome-temporally associated to SARS-CoV-2 infection (PIMS-TS), sharing …
Multisystem Syndrome-temporally associated to SARS-CoV-2 infection (PIMS-TS), sharing …
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label …
Objective To assess the long-term efficacy and safety of infliximab plus methotrexate in
juvenile rheumatoid arthritis (JRA). Methods Patients eligible for the open-label extension …
juvenile rheumatoid arthritis (JRA). Methods Patients eligible for the open-label extension …